Head-to-head · Value Score
Gimme Care vs NexLife
Two GLP-1 deals, scored on the same six factors. Gimme Care lands a Value Score of 91, NexLife a 72. Here's who gives you the honest lower price — and where each one bites back.
Gimme Care
#5 · Grade A · Best Value
Est. first month
$130/mo
Save ~90% vs brand-nameNexLife
#200 · Grade C · Watch List
Est. first month
From $145/mo (12-month plan, compounded)
Save ~89% vs brand-nameThe verdict
Gimme Care takes it on Value Score, 91 to 72 — an est. $130/mo first month, with no teaser step-up baked in. NexLife isn't out of it: Shoppers who want pharmacy-quality-conscious patients seeking LegitScript + NABP-certified compounded GLP-1.
Deal-by-deal
The numbers that decide it. Green ✓ marks the stronger side on each line.
| Deal | Gimme Care | NexLife |
|---|---|---|
| Value Score | 91 (A) | 72 (C) |
| Est. first month | $130/mo | From $145/mo (12-month plan, compounded) |
| Save vs brand-name | ~90% | ~89% |
| Semaglutide | $130/mo | From $145/mo (12-month plan, compounded) |
| Tirzepatide | $163/mo | From $186/mo (12-month plan, compounded) |
| Both molecules | Yes | Yes |
| Pricing | Flat — no step-up | Watch |
| Coverage | All 50 states | Coverage not published |
Factor by factor
The six factors behind each Value Score. The orange bar marks the stronger side. See the methodology.
Gimme Care
Genuinely cheap on both molecules ($130 / $163) with a LegitScript-certified pharmacy and all-50-state reach.
Why it's a deal
- Low flat price on both molecules ($130 sema / $163 tirz)
- LegitScript-certified pharmacy
- Available in all 50 states
The fine print
- No brand-name option — compounded only
- No oral/sublingual form
NexLife
NexLife is a LegitScript-certified telehealth platform offering compounded semaglutide (from $145/mo) and compounded tirzepatide (from $186/mo).
Why it's a deal
- LegitScript certified platform
- Works exclusively with LegitScript-certified, NABP-accredited pharmacies — strongest pharmacy trust signal in the dataset
- Both semaglutide and tirzepatide at competitive pricing
- Semaglutide from $145/mo on the 12-month plan ($165/mo month-to-month) - among the lowest in the dataset
The fine print
- State availability not publicly disclosed
- Compounded only — no brand-name options
- Also covers hormone optimization and longevity
- Lowest advertised rates ($145 sema / $186 tirz) require a 12-month plan commitment
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Value Score.
Neither one the right fit? Every program that outscores Gimme Care is ranked on the Gimme Care alternatives board, and the same list for the other side is on alternatives to NexLife.
More head-to-heads
Prices, states and verification reflect each program's public disclosures at last check; the Value Score is our editorial judgment per the methodology. “Save vs brand-name” compares the lowest disclosed monthly price against a ~$1,349/mo brand-name cash reference. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.